KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $538,124 | +2.3% | 4,639 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $526,069 | +53.0% | 4,481 | +4.3% | 0.00% | +100.0% |
| Q1 2023 | $343,938 | -10.9% | 4,296 | -11.8% | 0.00% | 0.0% |
| Q4 2022 | $386,039 | +22.6% | 4,873 | +8.0% | 0.00% | 0.0% |
| Q3 2022 | $315,000 | +10.5% | 4,511 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $285,000 | -32.8% | 4,350 | -31.8% | 0.00% | 0.0% |
| Q1 2022 | $424,000 | -14.0% | 6,378 | -9.5% | 0.00% | 0.0% |
| Q4 2021 | $493,000 | +34.0% | 7,046 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $368,000 | -37.4% | 7,041 | -18.5% | 0.00% | -50.0% |
| Q2 2021 | $588,000 | +8.1% | 8,641 | +22.4% | 0.00% | 0.0% |
| Q1 2021 | $544,000 | +50.3% | 7,060 | +16.9% | 0.00% | +100.0% |
| Q4 2020 | $362,000 | – | 6,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |